In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

Fintel reports that on January 8, 2025, UBS upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Sell to Buy. Analyst ...

Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Neutral ...

A patient advocacy group has started a campaign to stop Novo Nordisk from following through ... basal insulins – used to provide a background dose of insulin – are not always suitable for ...

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for investors. Nvidia has become synonymous with the term "semiconductor," but ...

Greenland's strategic location also makes it valuable to the US. An existing US base, Pituffik Space Base , is key to US ...

Shares in Danish drugmaker Novo Nordisk NVO, known for its blockbuster ... on Nordic investors and Nordic companies. Englundh has a background as a financial journalist at Nyhetsbyrån Direkt ...

Basal insulin therapy, currently administered either once or twice daily, is a well-established therapy for diabetes, providing a background ... as daily dosing with Novo Nordisk's Tresiba ...

US equity benchmarks were mixed on Wednesday as stronger than expected employment data raised concerns over future pace of ...

An under-the-radar case being considered by the Supreme Court could have a significant impact on rural health care.

Obesity rates decline in U.S. for first time in decade, driven by Souths medication usage Obesity decline signals potential ...